NEURO NEWS
Neurological News with information about conditions, treatments, current studies and breakthroughs.
Rapid Relief: Transform Your Mood with TMS in Days!
Abstract: Addressing the complex interplay of pharmacoresistant major depressive disorder (MDD) and posttraumatic stress disorder (PTSD) in US military veterans, [...]
Revolutionizing Recovery: Theta-Burst Transcranial Magnetic Stimulation in Post-Stroke Dysphagia
Introduction: Diving into the uncharted territories of post-stroke dysphagia recovery, a groundbreaking study titled "Theta-Burst Transcranial Magnetic Stimulation for Dysphagia [...]
Accelerated Healing: TMS – Your Shortcut to Mental Wellness
Introduction: Unraveling new avenues for addiction therapy, a recent pilot study titled "Twice-Daily Theta Burst Stimulation of the Dorsolateral Prefrontal [...]
Revolutionizing Depression Treatment: Dash TMS Protocol for Short Treatment
Embark on a journey into the future of depression treatment with the groundbreaking study featured in "Brain Stimulation." This research, [...]
TMS Breakthrough: Elevate Your Mood in a Matter of Days!
Embark on a transformative journey with Accelerated Transcranial Magnetic Stimulation (aTMS), a revolutionary therapy designed to expedite recovery for various [...]
Unlocking the Power of Transcranial Magnetic Stimulation (TMS): Insights from Dr. Khademi’s Workshop at Beth Israel Medical Center
Unveiling the Future: Dr. Khademi's Workshop Sheds Light on TMS Revolution In a groundbreaking workshop at Beth Israel Medical Center, [...]
- Medicinal Signaling Cell Therapy Fast Tracked for Mild Alzheimer Disease July 29, 2024The investigational allogeneic cellular therapy is believed to impart anti-inflammatory, pro-vascular, and pro-regenerative effects.
- Endo Recalls Clonazepam ODT Due to Carton Label Displaying Incorrect Strength July 29, 2024The product is being recalled because the incorrect strength of 0.125mg is appearing on the carton labels.
- Investigational Gene Therapy for Parkinson Disease Gets Fast Track Status July 22, 2024AB-1005 is an investigational gene therapy based on AAV2 containing the human GDNF transgene.
- FDA Approves Aflibercept Biosimilar Ahzantive July 16, 2024Ahzantive is a vascular endothelial growth factor inhibitor.
- Ketamine May Reduce Cluster Headache Symptoms July 2, 2024Researchers sought to evaluate ketamine as a potentially promising treatment approach.
Get Social